Treatment of life-threatening hemangiomas of childhood

C. A. Corpron, R. J. Andrassy, R. K. Singh, L. M. Ellis

Research output: Contribution to journalReview articlepeer-review

Abstract

HEMANGIOMAS ARE the most common tumor of infancy. Although a majority of these tumors regress without treatment by age 10, a small percentage may cause serious complications, such as obstruction of visual, auditory, digestive or respiratory systems, ulceration and intractable pain, high output cardiac failure, and thrombocytopenia. Although options for treatment of these tumors include surgical resection, chemotherapy, embolization, laser therapy, and radiotherapy, they have been largely abandoned for corticosteroid treatment. More recently, interferon-2 alpha (IFN-2α) has been used to treat children with steroid-resistant hemangiomas and may be the choice in children with life-threatening hemangiomas.

Original languageEnglish (US)
Pages (from-to)408-411
Number of pages4
JournalCancer Bulletin
Volume47
Issue number5
StatePublished - 1995
Externally publishedYes

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Treatment of life-threatening hemangiomas of childhood'. Together they form a unique fingerprint.

Cite this